Roche Amplicor HPV Test To Battle With Digene: A David & Goliath Scenario?
This article was originally published in The Gray Sheet
Executive Summary
Roche Diagnostics' plan to obtain a CE mark by the second quarter for its Amplicor human papillomavirus PCR-based test and complete U.S. trials by Q2 2005 has Digene scurrying to maintain its DNAwithPap first-to-market advantage